Renalytix Plc Stock
Stocks
RENX
GB00BYWL4Y04
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.900 GBX | 0.00% |
|
0.00% | -67.80% |
| 05-12 | Renalytix PLC And Carna Health Partner To Solve Kidney Disease Crisis | CI |
| 04-22 | EARNINGS AND TRADING: PensionBee sales jump 38%; Insig AI CEO invests | AN |
| Market Cap | 10.97M 9.61M 8.87M 8.28M 15.59M 1.04B 15.95M 107M 41.21M 512M 41.21M 40.31M 1.78B | P/E 2024 |
-0.45x | P/E 2025 | -1.34x |
|---|---|---|---|---|---|
| Enterprise Value | 15.57M 13.64M 12.59M 11.76M 22.13M 1.47B 22.63M 151M 58.48M 726M 58.49M 57.2M 2.52B | EV / Sales 2024 |
11,059,330x | EV / Sales 2025 | 12,499,418x |
| Free-Float |
73.31% | Yield 2024 * |
-
| Yield 2025 | - |
| Current month | +5.56% | ||
| 1 month | +5.56% | ||
| 3 months | -9.52% | ||
| 6 months | -67.24% | ||
| Current year | -67.80% |
| 1 week | 1.8 |  | 2 |
| 1 month | 1.6 | | 2 |
| Current year | 1.6 | | 6.5 |
| 1 year | 1.6 | | 15.5 |
| 3 years | 1.6 | | 150 |
| 5 years | 1.6 | | 1,190 |
| 10 years | 1.6 | | 1,220 |
| Manager | Title | Age | Since |
|---|---|---|---|
James McCullough
CEO | Chief Executive Officer | 58 | 2018-03-14 |
Joel Jung
DFI | Director of Finance/CFO | 68 | 2024-05-27 |
Howard Doran
PSD | President | 65 | 2024-04-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Julian Baines
CHM | Chairman | 62 | 2024-11-04 |
James McCullough
BRD | Director/Board Member | 58 | 2018-03-14 |
| Chairman | 74 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02-12 | Buy | Founder | 250 | 0.0001% | ||
| 02-12 | Buy | Chief Financial Officer | 500 | 0.0001% | ||
| 02-12 | Buy | Founder | 500 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | -73.79% | -97.47% | 10.97M | |
| -0.04% | +5.12% | +1.08% | -26.08% | 16.08B | |
| +4.39% | -3.68% | +24.34% | +86.48% | 1.44B | |
| -0.26% | -1.86% | -32.48% | +26.06% | 1.09B | |
| +20.20% | +49.92% | -35.65% | -77.23% | 940M | |
| +3.30% | -6.67% | -24.00% | -52.92% | 608M | |
| +5.86% | +7.83% | -35.56% | -54.51% | 561M | |
| -2.33% | -3.37% | +15.92% | -56.68% | 434M | |
| -0.48% | -0.48% | -55.18% | -60.69% | 380M | |
| -0.44% | -0.29% | -25.52% | -26.49% | 334M | |
| Average | +4.71% | -1.61% | -24.08% | -33.95% | 2.19B | |
| Weighted average by Cap. | +2.26% | +3.00% | -3.40% | -20.99% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.29 2 1.85 1.73 3.25 216.41 3.33 22.27 8.6 106.76 8.6 8.41 370.67 | 3 2.63 2.42 2.26 4.26 283.63 4.36 29.18 11.27 139.93 11.27 11.02 485.81 |
| Net income | -33.46M -29.29M -27.04M -25.25M -47.54M -3.16B -48.62M -325M -126M -1.56B -126M -123M -5.42B | -20.4M -17.86M -16.49M -15.4M -28.99M -1.93B -29.65M -198M -76.61M -951M -76.61M -74.93M -3.3B |
| Net Debt | 3.86M 3.38M 3.12M 2.91M 5.48M 364M 5.6M 37.5M 14.48M 180M 14.48M 14.16M 624M | 4.6M 4.03M 3.72M 3.47M 6.54M 435M 6.69M 44.75M 17.27M 215M 17.27M 16.9M 745M |
Employees
46
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-29 | GBX 1.900 | 0.00% | 70,113 |
| 26-06-26 | GBX 1.900 | 0.00% | 35,217 |
| 26-06-25 | GBX 1.900 | 0.00% | 104,107 |
| 26-06-24 | GBX 1.900 | 0.00% | 260,119 |
| 26-06-23 | GBX 1.900 | 0.00% | 244,919 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RENX Stock
Select your edition
All financial news and data tailored to specific country editions
